Search clinical trials for: 14-042

Total 7555 results

Memorial Sloan Kettering Cancer Center

Completed

The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC

Inpatients With Limited English Proficiency

United States
Baptist Health South Florida
University of California, Los Angeles; Quest Diagnostics-Nichols Insitute

Active, not recruiting

The Miami Heart Study at Baptist Health South Florida (MiHEART)

Cardiovascular Disease

United States
University Hospital, Clermont-Ferrand
World Rugby Research Unit

Unknown

Blood Biomarkers for the Management of Concussion in Professional Rugby Players (RUGBYPROS100B)

Concussion | Professional TOP14 Rugby Players

France
Mayo Clinic
Celerion; Anexon, Incorporated

Completed

ANX-042 Healthy Volunteer Dose Escalation Study

Healthy Volunteers

United States
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute; Stanford University

Active, not recruiting

Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

Lymphoma | Relapsed/Refractory T-cell Lymphomas

United States
University of Malaya

Unknown

Comparing Clinical Application of Innovatedly Made Transpalatal Arch (TPA) From 3D Reconstructed Model and Conventionally Made TPA

Transpalatal Arch (TPA) | Oral Health Related Quality of Life (OHRQoL) | Oral Health Impact Profile Short Version 14 (OHIP 14) | Orthodontic Pain | Three Dimensional (3D) Orthodontic Device

Malaysia
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions

Healthy

India
Diwakar Davar
Tesaro, Inc.

Recruiting

Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma

Melanoma Stage IV | Melanoma Stage III

United States
ImmunityBio, Inc.

Not yet recruiting

IBRX-042 In Subjects With HPV-Associated Tumors

HPV-Related Carcinoma
Chungbuk National University Hospital
Merck KGaA, Darmstadt, Germany

Recruiting

Tepotinib in Solid Tumors Harboring MET Alterations

Solid Tumor | MET Amplification | MET Exon 14 Skipping Mutation

Korea, Republic of
Tesaro, Inc.

Completed

Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants

Neoplasms

United States
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Enrolling by invitation

Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome (ANX-042 Aim 1)

Heart Failure | Cardiorenal Disease | Renal Disfunction

United States
KeyBioscience AG
Nordic Bioscience A/S

Completed

Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Denmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
State Budgetary Healthcare Institution, National...

Recruiting

First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) (HL-Russia-1)

Hodgkin Lymphoma, Adult

Russian Federation
Pulmotect, Inc.
WCCT Global

Completed

Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)

Healthy

United States
Rennes University Hospital
LTSI-INSERM U1099; CIC-IT 14-14

Completed

Sensors for HEalth Recording and Physical Activity Monitoring (SHERPAM)

Physical Activity

France
Memorial Sloan Kettering Cancer Center

Recruiting

Germ Cell Tumor and Testicular Tumor DNA Registry

Germ Cell Tumor | Testicular Tumor

United States
International Centre for Diarrhoeal Disease Research...

Completed

Immunogenicity of SA 14-14-2 JE Vaccine

Healthy Infants

Bangladesh
Memorial Sloan Kettering Cancer Center
MethylGene Inc.

Terminated

Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Lymphoma | Relapsed and Refractory | Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

United States
Memorial Sloan Kettering Cancer Center
AstraZeneca; MedImmune LLC

Completed

Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer

Advanced Colorectal Cancer

United States
Italian Sarcoma Group
GlaxoSmithKline

Terminated

Study on TSR-042 in Advanced Clear Cell Sarcoma (ACCeSs)

Sarcoma, Clear Cell

Italy
Columbia University
Pfizer

Completed

Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy

Uveal Melanoma

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Nintedanib in Patients With Advanced Esophagogastric Cancer

Esophagogastric Adenocarcinoma

United States
Memorial Sloan Kettering Cancer Center
The City College of New York

Completed

Yoga Practice for Breast or Ovarian Cancer Patients

Breast Cancer | Ovarian Cancer

United States
Grupo Español de Investigación en Cáncer de Ovario
Apices Soluciones S.L.; TESARO/GSK

Active, not recruiting

TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation (ATOMICC) (ATOMICC)

Cervical Cancer | Advanced Cancer

Spain, Turkey
Memorial Sloan Kettering Cancer Center

Recruiting

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

Bladder Cancer

United States
Memorial Sloan Kettering Cancer Center
Fordham University

Active, not recruiting

Identifying and Measuring Depression in Older Cancer Patients

Older Cancer Patients

United States
Memorial Sloan Kettering Cancer Center
Ohio State University; Pharmacyclics LLC.; Janssen Biotech, Inc.

Completed

Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma

T-cell Lymphoma | Relapsed and Refractory T-cell Lymphoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer

Papillary Thyroid Cancer

United States
University Hospital, Montpellier

Completed

Accuracy of eDiagEPU, a Medical Computerized Tool for EPU (eDiagEPU)

Pregnant Women Less Than 14 Weeks of Gestation

France
Merck Sharp & Dohme LLC

Completed

Instrument Utility for Suspected Asthma (0000-042)(COMPLETED)

Asthma
Memorial Sloan Kettering Cancer Center
Novartis

Completed

Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Lymphoma | Primary Central Nervous System Lymphoma | Recurrent/Refractory Secondary Central Nervous System Lymphoma

United States
Ondokuz Mayıs University

Completed

Oral Health Related Quality of Life and Periodontal Diseases

Periodontal Diseases
Memorial Sloan Kettering Cancer Center
New York University; The City College of New York; New York State Department...

Completed

DRIIVE (Data and Research on Interventions to Improve the Vehicular Environment)

Vehicular Environment

United States
Memorial Sloan Kettering Cancer Center
Weizmann Institute of Science; Cold Spring Harbor Laboratory

Completed

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Pancreatic Cancer

United States
Memorial Sloan Kettering Cancer Center
Novartis Pharmaceuticals; Incyte Corporation

Active, not recruiting

Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older

Acute Lymphoblastic Leukemia

United States
Memorial Sloan Kettering Cancer Center

Completed

Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification

Breast Cancer

United States
Al-Azhar University

Completed

14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid Arthritis

Rheumatoid Arthritis | Osteoporosis

Egypt
Maastricht University Medical Center

Completed

NMES During the Day and Prior to Sleep (ESPRO2)

Sarcopenia

Netherlands
Shin Nippon Biomedical Laboratories, Ltd.

Completed

Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting

Chemotherapy-Induced Nausea and Vomiting

United States
University of Iowa

Recruiting

Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers (NAIO)

Colon Cancer | dMMR Colorectal Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer

Bladder Cancer | High Risk Superficial

United States
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche; Genentech, Inc.; Hartford HealthCare

Active, not recruiting

Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy

Metastatic HER2-Positive Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases

Synovial Sarcoma | Single or Multiple Lung Metastases

United States
GlaxoSmithKline

Recruiting

A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)

Neoplasms, Rectal

United States, France, Italy, Japan, Spain, United Kingdom, Germany, Korea, Republic of, Canada, Netherlands
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma

Neuroblastoma

United States
Memorial Sloan Kettering Cancer Center
Tesaro, Inc.

Active, not recruiting

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

Endometrial Cancer

United States
Merck Sharp & Dohme LLC

Completed

Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042)

Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center

Completed

Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation

Childhood Cancer Survivors Treated With Abdominal Radiation

United States

Search clinical trials for: 14-042

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations